Let us help you on your journey to Pharmac Funded Technology
If you're a New Zealander with type 1 diabetes, you may have heard that Pharmac has approved funding for CGMs, insulin pumps and consumables from 1st October 2024.
Visit the Pharmac website for more information, or join our waitlist for updates as we learn more about funding.
Pharmac Funded Products
Get to know the products Pharmac approved for funding:
- Dexcom CGM Systems
- Tandem t:slim X2™ insulin pump and consumables
What is continuous glucose monitoring (CGM)?
Dexcom CGM Systems are a diabetes management tool that measures glucose levels 24 hours a day using a sensor inserted just under the skin. The wearable automatically sends glucose readings to a compatible device such as phone or an optional Receiver.† It provides you real-time glucose readings with zero fingerpricks* and it can also alert you when your glucose levels are too high or drop too low.
Dexcom CGM Systems provide proven accuracy1, allowing you to make better informed treatment decisions.
†Smart device and Receiver not included with Dexcom CGM System. For a list of compatible devices, please visit dexcom.com/compatibility
The Dexcom Difference
Manage diabetes confidently and achieve real results with Dexcom
Whatever your diabetes needs are, we have a real-time CGM for you. Explore our range of products.
† Smart device not included with the Dexcom CGM System. For a list of compatible devices, please visit dexcom.com/compatibility.
An easy CGM with essential glucose alerts
An advanced CGM with insulin pump connectivity and predictive alerts
How do insulin pumps work
An insulin pump is a small medical device that helps you with your diabetes management, replacing the need for frequent insulin injections.
It delivers precise doses of rapid-acting insulin 24 hours a day, to keep glucose levels steady between meals and during sleep. This is called basal insulin. Basal insulin is adjustable throughout the day and night to meet changing insulin needs.
Let Tandem do the thinking for you
with the t:slim X2™ insulin pump with Control-IQ™ technology
An insulin pump, particularly when paired with a CGM, can improve your diabetes management.
Tandem t:slim X2 insulin pump with Control-IQ technology predicts glucose levels 30 minutes ahead using data from the Dexcom CGM, allowing for automatic insulin delivery that predicts and helps prevent highs and lows.
When life gets busy, the fear of going low can really get in your way. Tandem t:slim X2 insulin pump with Control-IQ technology works with you 24/7 to help you live more freely.
Tandem t:slim X2 insulin pump and consumable are fully funded for eligible patients through Pharmac funding.
Want to learn more about our products?
Discover how CGM technology and the Tandem insulin pump and can transform your diabetes management. Get more information below:
Dexcom ONE+
Dexcom G7
Looking to switch to
Tandem t:slim X2 insulin pump?
If you're considering switching to the Tandem t:slim X2™ insulin pump, you will need to speak to your healthcare professional to see if this pump is right for you.
Alternatively, you can contact our NZMS Diabetes team at 0800 500 226 or email us at [email protected] for more information.
Have any questions or feedback?
We're here for you
We aim to answer all your questions and hope this page provides you with the information you need.
If you have any feedback or additional questions, please don’t hesitate to email us.
If you're interested in upgrading your insulin pump software so that you can connect to Dexcom G7, please schedule a call with one of our inside sales team members.
Frequently Asked Questions
Under Pharmac's proposal, will I receive funding for Dexcom G6 and G7 even if I don’t want to connect to a pump?
I’m currently on a funded Tandem insulin pump, is there anything I can do to get ready for Pharmac Funding?
I am eligible for Pharmac Funding. How do I get my products?
How many Dexcom CGM Sensors can I get per year?
I am living with type 1 diabetes and currently purchasing Dexcom CGM outright. What should I do?
What if I want to get started on Dexcom CGM and I am not eligible for Pharmac funding?
Are Dexcom CGMs compatible with any insulin pump?
How to get started on the t:slim X2 insulin pump with Control-IQ technology?
How to upgrade my Tandem t:slim X2 insulin pump with Basal-IQ technology to Control-IQ technology?
Do you have any additional resources for me to learn more about Dexcom CGMs or the Tandem t:slim X2 insulin pump?
What support will I have from NZMS Diabetes?
As a pharmacist interested in stocking CGM, insulin pumps, or consumables, whom should I contact for more information?
Speak to your Diabetes Healthcare Team
Dexcom CGM systems, Tandem t:slim X2 insulin pump and consumables are fully funded for eligible Type 1 diabetes patients through Pharmac funding. We encourage you to reach out to your Diabetes Healthcare Team to see if the product is right for you.
Contact us
Call our 24/7 technical support line on 0508 634 103 and we will do our best to assist you. Alternatively, if you’d like to report an issue with your Dexcom CGM or provide feedback, please reach out to our technical support team.
Shop Now
Not eligible for Pharmac Funding? Visit our online store at NZMS Diabetes (a Dexcom Company).
Useful Resources
Find all our useful resources such as brochures and flyers via NZMS Diabetes (a Dexcom Company).
Always read the label and use only as directed. Read the warnings available on nzmsdiabetes.co.nz/resources before purchasing. Consult your healthcare professional to see if this product is right for you. Tandem t:slim X2 insulin pump with Control-IQ technology provides continuous delivery of insulin through a subcutaneously applied infusion set. The algorithm will adjust insulin delivery according to the predicted glucose when used with a compatible CGM.
*If glucose alerts and readings from the Dexcom CGM do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions. † Smart device and Receiver not included with Dexcom CGM System. For a list of compatible devices, please visit dexcom.com/compatibility. 1. Welsh JB, et al. J Diabetes Sci Technol. 2024;18(1):143-7.